Informations générales (source: ClinicalTrials.gov)
The Lyon Real World Evidence in Metastatic NeuroEndocrine Tumours (LyREMeNet)
Observational
Hospices Civils de Lyon (Voir sur ClinicalTrials)
juillet 2017
juillet 2020
29 juin 2024
Neuroendocrine tumours (NETs) are rare and include a heterogeneous group of neoplasms
derived from the endocrine system found in the gastrointestinal tract, pancreas and lung.
Gastroenteropancreatic (GEP) NETs represent the majority of neuroendocrine neoplasms
(NEN) and the annual incidence of all GEP-NETs has been estimated to 6.98 per 100,000
person-years in 2012 and is steadily rising. While data on the incidence of metastatic
GEP-NET is limited, more than 50% of patients with GEP-NET have metastatic disease at the
time of diagnosis. Incorrect and delayed diagnoses are still common. Treatment options
include surgery, locoregional interventions, and systemic treatment.
The Lyon Real world Evidence in Metastatic NeuroEndocrine Tumours study (LyREMeNET) is a
descriptive observational cohort study. The main objective is to assess the healthcare
resources use and the corresponding costs for management of patients with metastatic GEP
and lung NETs. The secondary objective is to describe the clinical characteristics,
prognostic factors, treatment patterns, and the overall survival among patients with
metastatic GEP and lung NETs.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hospices Civils de Lyon - 69003 - Lyon - France | THOMAS WALTER, Dr | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients with a diagnosis of well-differentiated metastatic neuroendocrine tumour
(either synchronous or metachronous)
- Diagnosis performed between 1 January 1990 and 31 December of 2017
- Patients seen at least once at the oncologic department of Hospices Civils de Lyon.
- Patients with a diagnosis of well-differentiated metastatic neuroendocrine tumour
(either synchronous or metachronous)
- Diagnosis performed between 1 January 1990 and 31 December of 2017
- Patients seen at least once at the oncologic department of Hospices Civils de Lyon.
- Poorly differentiated neuroendocrine carcinoma
- Histologic mixed neuroendocrine tumour